Os03g0621600 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
Os03g0621600 antibody; LOC_Os03g42370 antibody; OSJNBb0111B07.17 antibody; Putative B3 domain-containing protein Os03g0621600 antibody
Target Names
Os03g0621600
Uniprot No.

Target Background

Subcellular Location
Nucleus.

Q&A

What is Os03g0621600 and why is it significant for antibody development?

Os03g0621600 is a gene located on chromosome 3 of rice (Oryza sativa) that encodes a protein involved in plant immunity responses. Antibodies targeting this protein are valuable for studying rice disease resistance mechanisms and potential biotechnological applications. Methodologically, researchers approach Os03g0621600 antibody development through recombinant protein expression of target epitopes, followed by immunization protocols optimized for plant protein antigens. The significance lies in the ability to detect and quantify this protein's expression under various biotic and abiotic stress conditions, providing insights into rice immunity pathways. Unlike conventional western blot approaches, Os03g0621600 antibody research often requires specialized extraction buffers containing protease inhibitors specific for plant tissues to prevent degradation of the target protein during sample preparation.

What expression systems are most effective for generating recombinant Os03g0621600 protein for antibody production?

For Os03g0621600 recombinant protein expression, bacterial, yeast, and plant-based expression systems each offer distinct advantages depending on research objectives. The methodological approach must consider protein solubility, post-translational modifications, and yield requirements.

Expression SystemAdvantagesLimitationsOptimization Strategies
E. coli (BL21)High yield, rapid growth, cost-effectiveLimited post-translational modifications, inclusion body formationUse fusion tags (MBP, SUMO), lower induction temperature (16°C), optimize codon usage
Yeast (P. pastoris)Proper folding, some post-translational modificationsLonger production time, more complex protocolsOptimize methanol induction timing, use strong promoters (AOX1)
Plant-based (N. benthamiana)Native-like modifications, proper foldingLower yield, time-consumingOptimize agroinfiltration protocols, use suppressor of silencing, harvest timing optimization
Insect cells (Sf9)Complex eukaryotic modificationsHigher cost, technical complexityOptimize MOI, harvest timing, supplement culture media

When selecting an expression system, researchers should consider whether the antibody will be used for detecting native protein or denatured epitopes. For conformational epitopes, eukaryotic expression systems generally yield higher-quality antigens despite lower yields. Purification should employ sequential chromatography approaches, starting with affinity purification followed by size exclusion to achieve >95% purity for immunization.

What are the recommended immunization protocols for developing high-affinity Os03g0621600 antibodies?

Developing high-affinity antibodies against Os03g0621600 requires carefully designed immunization strategies. The methodological approach includes proper antigen preparation, adjuvant selection, and immunization scheduling optimization.

For primary immunization, complete Freund's adjuvant mixed with 50-100 μg of purified Os03g0621600 protein yields optimal results. Subsequent booster immunizations should utilize incomplete Freund's adjuvant at 3-week intervals. The choice of host animal significantly impacts antibody specificity, with rabbits typically producing antibodies with higher affinity for plant proteins than mice.

Pre-immune serum collection is essential for establishing baseline cross-reactivity. After the third boost, perform ELISA screening with 1:5000 to 1:10000 dilution series to monitor antibody titer development. When titers plateau (typically after 4-5 immunizations), final serum collection or spleen harvest (for monoclonal antibody development) should be performed.

For monoclonal antibody development, hybridoma screening should include both positive selection (against Os03g0621600) and negative selection (against closely related rice proteins) to minimize cross-reactivity issues that commonly complicate plant protein research.

How should researchers optimize protein extraction protocols specifically for Os03g0621600 detection?

Optimizing protein extraction for Os03g0621600 detection requires addressing plant-specific challenges including cell wall interference, proteolytic activity, and secondary metabolites. The methodological approach focuses on buffer optimization and sample handling.

A recommended extraction buffer composition includes:

ComponentConcentrationPurpose
Tris-HCl (pH 7.5)50 mMBuffer system
NaCl150 mMIonic strength
EDTA5 mMChelating agent
Triton X-1000.5%Membrane solubilization
Glycerol10%Protein stabilization
DTT2 mMReducing agent
PVPP2% (w/v)Phenolic compound removal
Protease inhibitor cocktail1XPrevents degradation

Sample preparation should include:

  • Flash-freezing tissue in liquid nitrogen

  • Grinding to fine powder while maintaining frozen state

  • Immediate homogenization in cold extraction buffer (4:1 buffer-to-tissue ratio)

  • Centrifugation at 20,000×g for 20 minutes at 4°C

  • Collection of supernatant while avoiding the interface layer

For particularly problematic samples, phenol extraction followed by ammonium acetate/methanol precipitation can remove interfering compounds that may cause high background in immunodetection assays.

How can researchers address epitope masking issues when detecting native Os03g0621600 protein in plant tissues?

Epitope masking represents a significant challenge in Os03g0621600 detection, particularly when the protein forms complexes with other immunity-related factors. Methodologically, researchers can implement several approaches to overcome this limitation.

Epitope accessibility can be improved through controlled protein denaturation using a gradient of urea concentrations (0-8M) to determine optimal conditions that expose the epitope while maintaining antibody recognition. For native protein detection, membrane proteins like Os03g0621600 often require specialized solubilization using detergents:

DetergentConcentrationApplication
Digitonin0.5-1%Mild solubilization, preserves protein-protein interactions
DDM0.1-0.5%Intermediate solubilization
SDS0.1%Strong solubilization, may denature epitopes
CHAPS0.5-1%Good for membrane proteins, maintains native structure

Pre-treatment of samples with protein crosslinkers at sub-optimal concentrations (0.1-0.5% formaldehyde) can sometimes stabilize protein conformations while preserving epitope accessibility. Additionally, enzymatic treatment with glycosidases may be necessary if Os03g0621600 undergoes glycosylation that obscures antibody binding sites.

For co-immunoprecipitation applications, a two-antibody approach targeting different epitopes of Os03g0621600 can overcome masking issues, with the first antibody used for pulldown and the second for detection. This prevents signal loss when a single epitope is inaccessible in protein complexes.

What are the most effective approaches for validating Os03g0621600 antibody specificity in knockout/knockdown studies?

Validating Os03g0621600 antibody specificity requires rigorous controls, particularly using genetic knockout/knockdown systems. The methodological approach should include multiple validation techniques to confirm antibody specificity beyond cross-reactivity testing.

CRISPR/Cas9-mediated knockout lines provide the gold standard for antibody validation. When generating such lines, target multiple exons of Os03g0621600 to ensure complete protein ablation. For RNAi-based knockdown, design constructs targeting unique regions to minimize off-target effects. Validation experiments should include:

  • Parallel immunoblotting of wildtype, knockout, and knockdown samples using standardized protein loading (25-50 μg total protein)

  • Signal quantification across biological replicates (minimum n=3)

  • Correlation analysis between transcript levels (RT-qPCR) and protein abundance

A critical validation approach involves complementation tests where:

  • The knockout line is transformed with Os03g0621600 variants (native, epitope-tagged, or mutated versions)

  • Antibody detection should restore signal in complemented lines but remain absent in knockout controls

  • Signal intensity should correlate with transgene expression levels

For further validation, heterologous expression in non-rice systems (e.g., Nicotiana benthamiana) can confirm antibody specificity when the protein is expressed against a background lacking rice proteins.

Importantly, researchers should verify that closely related rice genes (paralogs) do not produce cross-reactive signals by testing antibody against recombinant paralogs or in plants overexpressing these related genes.

How can researchers optimize immunofluorescence protocols for subcellular localization of Os03g0621600?

Optimizing immunofluorescence for Os03g0621600 subcellular localization requires addressing plant-specific challenges including cell wall penetration, autofluorescence, and fixation protocols. The methodological approach focuses on tissue preparation and imaging optimization.

For tissue fixation, a recommended protocol includes:

  • Fix tissues in 4% paraformaldehyde with 0.1% glutaraldehyde in PBS (pH 7.4) for 2 hours

  • Include a cell wall permeabilization step using 0.1% cellulase and 0.05% macerozyme for 15-30 minutes at room temperature

  • Permeabilize with 0.5% Triton X-100 for 30 minutes to facilitate antibody penetration

  • Block with 3% BSA supplemented with 5% normal serum from the secondary antibody host species

To minimize autofluorescence:

  • Include 0.1% sodium borohydride in PBS during a 10-minute pre-treatment

  • Add 0.1% Sudan Black B in 70% ethanol after secondary antibody incubation

  • Consider using confocal settings with narrower bandpass filters or spectral unmixing

For co-localization studies, combine Os03g0621600 antibody detection with established organelle markers:

OrganelleMarkerFluorophore Recommendation
Plasma membranePIP2;1Cy5 (far-red range to avoid autofluorescence)
Endoplasmic reticulumBiPAlexa Fluor 555
Golgi apparatusManIAlexa Fluor 488
NucleusHistone H2BPacific Blue

Z-stack imaging with deconvolution significantly improves signal resolution when localizing Os03g0621600 to membrane compartments. Quantitative co-localization analysis using Pearson's or Manders' coefficients provides statistical support for localization claims, essential for publication-quality results.

What strategies can address contradictory data when Os03g0621600 antibody results conflict with transcript analysis?

When antibody-based detection of Os03g0621600 protein conflicts with transcript abundance data, several methodological approaches can resolve these contradictions through systematic investigation of potential biological and technical factors.

First, examine post-transcriptional regulation possibilities:

Regulatory MechanismInvestigation ApproachControls/Validation
microRNA targetingSequence analysis for miRNA binding sites, degradome sequencingmiRNA inhibitor treatment to rescue protein levels
Translation efficiencyPolysome profiling of Os03g0621600 mRNAAnalysis of 5'UTR regulatory elements
Protein stabilityCycloheximide chase assays with time-course samplingProteasome inhibitor (MG132) treatment
Alternative splicingRT-PCR with exon-spanning primersSequencing of PCR products, epitope mapping relative to splice variants

Second, verify technical aspects of both transcript and protein detection:

  • For transcript analysis:

    • Ensure primers span exon-exon junctions specific to Os03g0621600

    • Validate reference genes for stability under experimental conditions

    • Consider absolute quantification methods like digital PCR

  • For protein detection:

    • Evaluate extraction efficiency using spike-in controls

    • Test multiple antibody concentrations (1:500 to 1:5000 dilutions)

    • Compare different detection methods (Western blot, ELISA, immunoprecipitation)

A rigorous approach to resolving contradictions includes generating transgenic rice lines expressing epitope-tagged Os03g0621600 under native promoter control, allowing parallel detection of native and tagged protein. This system provides internal validation and can reveal regulatory mechanisms affecting protein accumulation independently of transcript levels.

What are the optimal conditions for using Os03g0621600 antibodies in various immunodetection techniques?

Optimizing Os03g0621600 antibody usage across different immunodetection techniques requires technique-specific protocol adjustments. The methodological approach varies significantly between Western blotting, immunoprecipitation, ELISA, and chromatin immunoprecipitation.

For Western blotting:

  • Protein transfer: Use PVDF membranes (0.45 μm) with 20% methanol transfer buffer for proteins >50 kDa; 0.2 μm membranes with 10% methanol for smaller fragments

  • Blocking: 5% non-fat milk in TBST provides optimal blocking while preserving epitope accessibility

  • Primary antibody: Incubate at 1:2000 dilution overnight at 4°C with gentle rocking

  • Detection: HRP-conjugated secondary antibodies (1:5000) with enhanced chemiluminescence provide best sensitivity-to-background ratio

For immunoprecipitation:

  • Pre-clearing: Critical for plant extracts; use 50 μL Protein A/G beads per 1 mg total protein for 1 hour at 4°C

  • Antibody binding: Use 2-5 μg antibody per 500 μg total protein

  • Incubation time: Extended to overnight for membrane-associated proteins like Os03g0621600

  • Wash stringency: Increasing salt concentration in sequential washes (150 mM to 300 mM NaCl)

For ELISA:

  • Coating concentration: 1-2 μg/mL purified antigen in carbonate buffer (pH 9.6)

  • Blocking: 3% BSA in PBS provides lower background than milk-based blockers

  • Antibody dilution: Titration series from 1:1000 to 1:10000 to determine optimal signal-to-noise ratio

  • Development time: Monitor kinetically to determine optimal endpoint before signal saturation

For chromatin immunoprecipitation (if applicable):

  • Crosslinking: 1% formaldehyde for 10 minutes, quenched with 125 mM glycine

  • Sonication: Optimize to generate 200-500 bp fragments, verified by agarose gel electrophoresis

  • Antibody amount: 5-10 μg per reaction, with IgG negative control in parallel

  • Elution: Two sequential elutions with freshly prepared elution buffer

How can researchers develop quantitative assays for measuring Os03g0621600 protein levels in different rice tissues?

Developing quantitative assays for Os03g0621600 requires careful calibration and validation across tissue types. The methodological approach focuses on establishing standard curves and addressing tissue-specific matrix effects.

For absolute quantification, produce and purify recombinant Os03g0621600 protein to establish standard curves:

  • Express full-length protein or the specific epitope region recognized by the antibody

  • Determine protein concentration using multiple methods (Bradford, BCA, and amino acid analysis)

  • Create standard curves spanning expected physiological range (typically 0.1-100 ng/μL)

For tissue-specific quantification, sandwich ELISA provides superior specificity:

ComponentSpecificationOptimization
Capture antibodyMonoclonal (2-5 μg/mL)Titrate to determine saturation point
Detection antibodyPolyclonal (0.5-2 μg/mL)Must recognize different epitope than capture antibody
Standard curve0.1-100 ng/mLInclude in each plate; prepare in extraction buffer from negative control tissue
Sample dilutionSerial dilutions (1:2, 1:5, 1:10)Must fall within linear range of standard curve

To address tissue-specific matrix effects:

  • Prepare standard curves in extraction buffer containing protein extract from os03g0621600-knockout plants

  • Implement spike-recovery experiments where known amounts of recombinant protein are added to extracts

  • Calculate recovery percentages and apply correction factors for each tissue type

For high-throughput applications, consider developing a multiplexed bead-based assay that simultaneously measures Os03g0621600 and related proteins in the same immune pathway. This approach increases throughput and reduces sample requirements while controlling for extraction variation across samples.

To validate quantitative assays:

  • Compare results across platforms (ELISA vs. Western blot quantification)

  • Analyze biological replicates (minimum n=5) to establish normal variation ranges

  • Calculate intra-assay (<10%) and inter-assay (<15%) coefficient of variation values

What are the most reliable approaches for determining antibody cross-reactivity with related rice proteins?

Determining antibody cross-reactivity requires systematic testing against potential cross-reactive proteins. The methodological approach combines in silico prediction, recombinant protein testing, and tissue-based validation.

Begin with computational analysis:

  • Identify proteins with sequence similarity to Os03g0621600 using BLAST (>30% identity in epitope region)

  • Analyze epitope conservation across rice proteome using epitope prediction algorithms

  • Generate a ranked list of potential cross-reactive proteins for experimental validation

For experimental validation, prepare a test panel:

Validation ApproachMethodologyAnalysis
Recombinant protein arrayExpress top 5-10 potential cross-reactive proteinsTest antibody binding at multiple dilutions (1:500-1:5000)
Peptide competitionPre-incubate antibody with excess epitope peptideShould eliminate specific signal but not cross-reactive signals
Western blot analysisRun Os03g0621600 alongside potential cross-reactive proteinsCompare band patterns and intensities
Immunoprecipitation-MSPerform IP followed by mass spectrometryIdentify all proteins pulled down by the antibody

For definitive analysis, test antibody against tissues from:

  • Wild-type plants (positive control)

  • os03g0621600-knockout plants (negative control)

  • Plants with individually overexpressed homologous proteins

Calculate cross-reactivity percentages using the formula:
(Signal intensity with homologous protein / Signal intensity with Os03g0621600) × 100%

Document cross-reactivity in a comprehensive table that researchers can reference when interpreting experimental results, including estimated detection thresholds for each cross-reactive protein.

How should researchers approach epitope mapping to enhance Os03g0621600 antibody applications?

Epitope mapping provides critical information for optimizing antibody applications and troubleshooting detection issues. The methodological approach includes computational prediction, peptide array analysis, and mutation studies.

Begin with computational epitope prediction:

  • Analyze Os03g0621600 sequence using BepiPred, IEDB, and CBTOPE algorithms

  • Identify regions with high surface accessibility, hydrophilicity, and flexibility

  • Generate consensus predictions across multiple algorithms

For experimental epitope mapping:

TechniqueMethodologyResolution Level
Peptide arraySynthesize overlapping peptides (15-mers with 5 aa overlap) spanning Os03g0621600Medium (5-10 aa)
Truncation analysisCreate sequential C-terminal and N-terminal truncationsLow (domain-level)
Alanine scanningSystematically replace individual residues with alanineHigh (single aa)
HDX-MSHydrogen/deuterium exchange mass spectrometryMedium-High (5-10 aa)

For conformational epitopes, more advanced approaches are necessary:

  • X-ray crystallography of antibody-antigen complexes (highest resolution but technically challenging)

  • Cryo-EM analysis of antibody-antigen complexes (moderate resolution)

  • Computational docking validated by mutational analysis

Epitope data should be used to:

  • Design detection strategies based on epitope accessibility in different experimental conditions

  • Create blocking peptides for specificity validation

  • Select optimal antibody pairs for sandwich assays that recognize distinct epitopes

  • Predict detection compatibility with protein fusion tags or interacting partners

A practical application of epitope mapping involves creating an epitope accessibility profile under different denaturing conditions, detergents, and pH values, enabling researchers to optimize detection protocols for specific experimental requirements.

How can researchers distinguish between specific and non-specific signals when using Os03g0621600 antibodies?

Distinguishing specific from non-specific signals requires implementing a systematic validation framework. The methodological approach involves multiple control experiments and quantitative signal analysis.

Essential validation controls include:

Control TypeImplementationExpected Outcome
Genetic knockoutTest os03g0621600-CRISPR/Cas9 linesComplete absence of specific signal
RNAi knockdownTest plants with variable knockdown efficiencySignal intensity correlates with transcript levels
Pre-immune serumUse serum collected before immunizationNo specific signal
Peptide competitionPre-incubate antibody with immunizing peptideDose-dependent reduction in specific signal
Secondary-onlyOmit primary antibodyEvaluates secondary antibody background
Isotype controlUse irrelevant antibody of same isotypeIdentifies Fc-mediated binding

For quantitative discrimination, implement signal-to-noise ratio (SNR) analysis:

  • Measure signal intensity in regions of interest (ROI) containing target protein

  • Measure background in equivalent ROIs from negative controls

  • Calculate SNR = (Signal - Background) / Standard Deviation of Background

  • Establish threshold SNR (typically >3) for positive detection

For Western blots specifically:

  • Verify that molecular weight matches theoretical prediction for Os03g0621600

  • Confirm band pattern consistency across biological replicates

  • Observe expected changes in response to experimental treatments

  • Document cases where additional bands appear consistently and at what relative intensity

For immunohistochemistry:

  • Compare staining patterns with previously reported subcellular localization data

  • Verify absence of signal in negative control tissues

  • Implement tissue clearing techniques to enhance signal specificity

  • Consider dual-labeling with known markers to confirm localization

What are the best practices for quantitative analysis of Western blot data for Os03g0621600 protein?

Quantitative Western blot analysis requires rigorous standardization and appropriate normalization. The methodological approach focuses on technical optimization and statistical analysis.

For sample preparation standardization:

  • Ensure equal protein loading (20-50 μg) confirmed by total protein stains (SYPRO Ruby or Ponceau S)

  • Include recombinant Os03g0621600 standards spanning the expected concentration range

  • Prepare all samples simultaneously using identical buffer compositions

  • Include biological replicates (minimum n=3) and technical replicates where sample quantity permits

For technical optimization:

  • Establish linear dynamic range for antibody detection using dilution series

  • Determine optimal exposure times that avoid signal saturation

  • Use fluorescent rather than chemiluminescent detection when possible for broader linear range

  • Implement automated image capture with defined settings across experiments

For normalization strategies:

Normalization MethodApplicationLimitations
Housekeeping proteinsTraditional approach (actin, tubulin)Expression may vary under stress conditions
Total protein normalizationStain-Free gels or Ponceau SMore reliable across experimental conditions
Loading control spike-inKnown concentration of non-plant proteinMost accurate but requires additional antibody
GAPDHCommon reference proteinMay change under oxygen stress conditions

For quantitative analysis:

  • Use image analysis software that measures integrated density values

  • Subtract local background from each band measurement

  • Normalize to appropriate reference (total protein preferred)

  • Calculate relative or absolute quantities using standard curves

  • Test for statistical significance using appropriate tests (ANOVA with post-hoc for multiple comparisons)

  • Report both raw and normalized values with standard deviation or standard error

How should researchers interpret variations in Os03g0621600 detection across different tissues and developmental stages?

Interpreting variations in Os03g0621600 detection requires distinguishing biological regulation from technical artifacts. The methodological approach combines controls, alternative detection methods, and biological context.

For developmental and tissue-specific profiling:

Tissue/StageTechnical ConsiderationsBiological Interpretation
Young leavesLower secondary metabolite interferenceExpression often linked to early defense priming
Mature leavesHigher ROS might modify epitopesMay correlate with acquired resistance status
RootsHigher proteolytic activity requires protease inhibitorsExpression patterns differ from aerial tissues
Reproductive tissuesComplex matrix effectsOften downregulated during reproductive development
Stress-inducedIncreased phenolics require PVPP in extractionUpregulation expected under specific stresses

To distinguish technical from biological variations:

  • Implement spike-in controls of recombinant Os03g0621600 to assess recovery efficiency

  • Compare protein detection with transcript levels from RT-qPCR

  • Use multiple antibodies targeting different epitopes of Os03g0621600

  • Employ absolute quantification methods calibrated for each tissue type

  • Document extraction efficiency by comparing multiple protocols

For biological interpretation:

  • Compare observed variations with published transcriptome data from public databases

  • Correlate protein levels with known stress responses or developmental programs

  • Consider post-translational modifications that might affect antibody recognition

  • Analyze protein turnover rates using cycloheximide chase experiments

  • Examine subcellular localization changes that might affect extraction efficiency

Statistical analysis should employ mixed-effects models that can account for both biological variation (tissue, development, treatment) and technical variation (extraction method, detection assay), allowing researchers to identify significant biological patterns separate from methodological limitations.

What approaches can resolve contradictory results between different antibody-based detection methods for Os03g0621600?

Resolving contradictions between different antibody-based methods requires systematic investigation of method-specific limitations. The methodological approach involves direct comparison experiments and troubleshooting of each technique.

First, document the specific nature of contradictions:

Detection Method ComparisonCommon ContradictionsInvestigation Approach
Western blot vs. ELISAQuantitative discrepanciesPerform parallel analysis of dilution series
Immunofluorescence vs. Western blotPresence/absence disagreementEvaluate extraction efficiency for membrane proteins
Co-IP vs. direct detectionInteraction-dependent detectionTest detergent and crosslinking variations
Native vs. denaturing conditionsSignal differencesEpitope accessibility analysis

For systematic resolution:

  • Epitope accessibility assessment:

    • Determine if epitopes are exposed differently in each method

    • Test detection after various denaturation treatments

    • Utilize multiple antibodies targeting different regions

  • Method-specific optimization:

    • For Western blot: Test reducing vs. non-reducing conditions

    • For ELISA: Compare direct, indirect, and sandwich formats

    • For immunofluorescence: Evaluate fixation and permeabilization protocols

    • For flow cytometry: Optimize cell isolation and antibody concentrations

  • Validation with orthogonal approaches:

    • Implement epitope tagging (FLAG, HA, or GFP) for parallel detection

    • Correlate results with mass spectrometry-based proteomic data

    • Use proximity ligation assays to verify protein interactions

    • Apply CRISPR/Cas9 editing to generate controls for all methods

A systematic troubleshooting matrix can help identify the source of contradictions:

  • Prepare identical samples and split for parallel processing

  • Systematically vary one parameter at a time (buffer, detergent, temperature)

  • Document all conditions where contradictions are resolved or exacerbated

  • Establish optimized protocols for each technique that yield concordant results

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.